24 March 2021 | News
India’s most economical Remdesivir brand now made more affordable for patients
Image credit- Zydus
In a significant move Ahmedabad based Zydus has made its brand of Remdesivir, Remdac more affordable at Rs. 899 for a 100 mg lyophilized injection.
Remdac which was launched in August 2020 at Rs. 2800, continues to be India’s most economical brand of Remdesivir and a critical drug in the treatment of COVID-19.
This move to further revise the prices will go a long way in helping patients during these critical times.
Speaking on the development Dr. Sharvil Patel, Managing Director, Cadila Healthcare Limited said, “Through the course of this pandemic, our efforts have been focused on making therapies accessible and affordable to people. RemdacTM has been one of the critical drugs in the disease management on COVID and we hope that this price cut will enable people from every strata of the society to access this critical drug.”